Nations vote 85-10 for ban on developing Aerosol nerve agents: US

A global prohibition on chemical weapons to tools for law enforcement won the approval of the Organization for the Prohibition of Chemical Weapons on an 85-10 vote, the US State Department said

chemicals
ANI US
2 min read Last Updated : Dec 02 2021 | 7:12 AM IST

A global prohibition on chemical weapons to tools for law enforcement won the approval of the Organization for the Prohibition of Chemical Weapons (OPCW) on an 85-10 vote, the State Department said on Wednesday.

"This decision sends a clear signal that countries cannot hide their work to advance an offensive capability for the aerosolized use of central nervous system-acting chemicals under the guise of doing so for law enforcement," the US State Department said in a statement

The US, in collaboration with Australia, Switzerland, and 49 other countries, cosponsored the decision, which was adopted by a super majority with 85 in favor and only ten voting against the decision, the statement said.

"The danger posed by these chemicals was initially highlighted by their ill-considered use by Russia in 2002 to end the Moscow Theatre siege, which left 129 hostages dead," it added.

The US has long been concerned that some countries are concealing their offensive work related to central nervous system-acting chemicals, by citing an exemption for developing tools for law enforcement, the statement said.

"Today's decision seeks to prevent the use of these chemicals as chemical weapons and ensures that States Parties' shared understanding is clearly memorialized," State Department added.

It said the vote effectively ended the exemption. The 193-nation OPCW oversees a global effort to permanently and verifiably eliminate chemical weapons, according to State Department.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :nerve agentChemicalsUnited States

First Published: Dec 02 2021 | 7:12 AM IST

Next Story